Pacer Advisors Inc. Has $266,000 Stake in DENTSPLY SIRONA Inc. $XRAY

Pacer Advisors Inc. reduced its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 90.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 22,973 shares of the medical instruments supplier’s stock after selling 219,888 shares during the period. Pacer Advisors Inc.’s holdings in DENTSPLY SIRONA were worth $266,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of DENTSPLY SIRONA during the 1st quarter valued at about $26,000. Eurizon Capital SGR S.p.A. acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth approximately $26,000. Caitong International Asset Management Co. Ltd boosted its position in DENTSPLY SIRONA by 337.9% during the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after purchasing an additional 2,122 shares during the period. Farther Finance Advisors LLC boosted its position in DENTSPLY SIRONA by 119.1% during the fourth quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after purchasing an additional 2,051 shares during the period. Finally, Performa Ltd US LLC grew its holdings in DENTSPLY SIRONA by 116.1% during the fourth quarter. Performa Ltd US LLC now owns 4,250 shares of the medical instruments supplier’s stock valued at $49,000 after purchasing an additional 2,283 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts have recently commented on XRAY shares. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Monday, August 3rd. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, May 7th. BMO Capital Markets restated a “market perform” rating and set a $13.00 price target on shares of DENTSPLY SIRONA in a report on Friday. Mizuho lowered their price target on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Finally, Barclays dropped their price objective on DENTSPLY SIRONA from $12.00 to $9.00 and set an “underweight” rating on the stock in a research note on Thursday, June 4th. Three investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $13.38.

Insider Activity at DENTSPLY SIRONA

In other news, Director Michael J. Barber acquired 15,175 shares of the firm’s stock in a transaction dated Thursday, June 11th. The shares were bought at an average price of $9.88 per share, with a total value of $149,929.00. Following the acquisition, the director owned 55,943 shares of the company’s stock, valued at $552,716.84. This trade represents a 37.22% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Brian P. Mckeon acquired 10,000 shares of the stock in a transaction dated Friday, June 12th. The shares were purchased at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the transaction, the director owned 10,000 shares of the company’s stock, valued at $101,200. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Over the last 90 days, insiders purchased 35,160 shares of company stock worth $351,179. Company insiders own 0.46% of the company’s stock.

DENTSPLY SIRONA Trading Down 0.4%

Shares of XRAY stock opened at $11.61 on Wednesday. The firm has a market capitalization of $2.31 billion, a P/E ratio of -4.22, a price-to-earnings-growth ratio of 1.42 and a beta of 0.85. DENTSPLY SIRONA Inc. has a 1 year low of $9.40 and a 1 year high of $14.86. The firm’s fifty day simple moving average is $11.84 and its 200 day simple moving average is $11.88. The company has a current ratio of 1.63, a quick ratio of 1.07 and a debt-to-equity ratio of 1.48.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The firm had revenue of $898.00 million during the quarter, compared to the consensus estimate of $889.93 million. During the same period in the prior year, the firm earned $0.52 EPS. The business’s revenue was down 4.1% on a year-over-year basis. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.46 EPS for the current year.

DENTSPLY SIRONA Profile

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.